1 terminated. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Terminated 1 |
Follow Morphological and Microscopic Findings: new trials by email Literature Review of Morphological and Microscopic Findings trials Research Report on Morphological and Microscopic Findings
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TRUST Study: Raptiva ® in Hand & Foot Psoriasis Efalizumab - anti CD11a recombinant human monoclonal antibody, Placebo - Chronic Plaque Psoriasis | Phase 4 | Terminated | Merck KGaA, Darmstadt, Germany | 76 | 2008-04-01 | 2014-02-27 |
Pathological Conditions, Signs and Symptoms (1)
Merck KGaA, Darmstadt, Germany (1)
Austria (1)